Japan Cell Therapy Market Size & Outlook, 2023-2030

The cell therapy market in Japan is expected to reach a projected revenue of US$ 699.2 million by 2030. A compound annual growth rate of 23.2% is expected of Japan cell therapy market from 2024 to 2030.
Revenue, 2023 (US$M)
$162.4
Forecast, 2030 (US$M)
$699.2
CAGR, 2024 - 2030
23.2%
Report Coverage
Japan

Japan cell therapy market highlights

  • The Japan cell therapy market generated a revenue of USD 162.4 million in 2023 and is expected to reach USD 699.2 million by 2030.
  • The Japan market is expected to grow at a CAGR of 23.2% from 2024 to 2030.
  • In terms of segment, autologous therapies was the largest revenue generating therapy type in 2023.
  • Allogeneic Therapies is the most lucrative therapy type segment registering the fastest growth during the forecast period.


Cell therapy market data book summary

Market revenue in 2023USD 162.4 million
Market revenue in 2030USD 699.2 million
Growth rate23.2% (CAGR from 2023 to 2030)
Largest segmentAutologous therapies
Fastest growing segmentAllogeneic Therapies
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAllogeneic Therapies, Autologous Therapies
Key market players worldwideNovartis AG ADR, Gilead Sciences Inc, Bristol-Myers Squibb Co, Johnson & Johnson, JCR Pharmaceuticals Co Ltd, JW (Cayman) Therapeutics Co Ltd Ordinary Shares, Atara Biotherapeutics Inc, Medipost, Beiersdorf AG, Nkarta Inc Ordinary Shares


Other key industry trends

  • In terms of revenue, Japan accounted for 3.4% of the global cell therapy market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, South Korea cell therapy market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 103.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cell Therapy Market Companies

Name Profile # Employees HQ Website

Japan cell therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell therapy market will help companies and investors design strategic landscapes.


Autologous therapies was the largest segment with a revenue share of 83.19% in 2023. Horizon Databook has segmented the Japan cell therapy market based on allogeneic therapies, autologous therapies covering the revenue growth of each sub-segment from 2018 to 2030.


The cell therapy market in Japan is driven by several initiatives undertaken by Japanese companies to increase access to cell therapies, coupled with the rising approvals & clinical trials for cell-based therapies, in the country.


For instance, in February 2023, Novo Nordisk A/S and Heartseed, Inc. achieved a significant milestone by administering the first dose to a patient in the phase 1/2 clinical study, known as the LAPiS Study, for HS-001 an investigational cell therapy targeting heart failure.


The clinical phase 1/2 of the LAPiS Study would enroll 10 individuals with advanced heart failure caused by an ischemic heart condition. Thus, such clinical studies & trials for various cell therapies targeting numerous conditions like cardiovascular disease and cancer are expected to boost the competition in the Japan cell therapy market.

Reasons to subscribe to Japan cell therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan cell therapy market databook

  • Our clientele includes a mix of cell therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan cell therapy market , including forecasts for subscribers. This country databook contains high-level insights into Japan cell therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan cell therapy market size, by therapy type, 2018-2030 (US$M)

Japan Cell Therapy Market Outlook Share, 2023 & 2030 (US$M)

Japan cell therapy market size, by therapy type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more